President Trump pressed US energy executives but received few public pledges to quickly invest the vast sums of money needed ...

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

Carlyle Group (CG) gets a HOLD as PE headwinds and overvaluation limit upside; 3Q25 miss and slower exits pressure returns.

IWL targets the 200 largest Russell 3000 names, delivering a 0.41% CAGR edge, solid risk-adjusted returns and growth-quality ...

Dollar General (DG) gets a Buy as fundamentals improve, higher-income traffic rises, and digital wins. Read here for a ...

Capricor Therapeutics recently more than tripled on positive Phase 3 HOPE-3 data for deramiocel in Duchenne muscular ...

Strong Buy: deep undervaluation, strong margins, clean balance sheet and Çöpler reopening catalyst. Read here for a detailed ...

J.B. Hunt (JBHT) stock analysis: strong operator but rally prices in recovery. I initiate JBHT with a Hold rating. See here ...

All 123 publicly traded US equity real estate investment trusts analyzed by S&P Global Market Intelligence traded below their ...

All four major banks show healthy asset growth into Q4 2025, reflecting both organic balance sheet expansion and exposure to ...

The credit markets begin 2026 on solid ground, buoyed by resilient corporate fundamentals, elevated yields and relatively low ...

MasTec (MTZ) posts record Q3 results as backlog hits $16.8B and EPS surges; see 2025 guidance, valuation and why it’s rated ...